UNV Medicine Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 25

Employees

  • Stock Symbol
  • UNVO-M

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $16.28
  • (As of Wednesday Closing)

UNV Medicine General Information

Description

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Tel Aviv
  • Israel
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Stock Exchange
TAE
Vertical(s)
Corporate Office
  • Tel Aviv
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UNV Medicine Stock Performance

As of 18-Nov-2026, UNV Medicine’s stock price is $16.28. Its current market cap is $5.35K with 329.00 shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.28 $16.33 $5.35K 329.00 22.71

UNV Medicine Financials Summary

As of 30-Jun-2022, UNV Medicine has a trailing 12-month revenue of $13.5M.

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 17,848 27,741 21,477 20,415
Revenue 13,549 13,038 9,785 231
EBITDA (7,723) 751 518 (3,131)
Net Income (9,938) (1,934) 53 (3,306)
Total Assets 21,871 32,545 23,012 14,110
Total Debt 12,092 12,513 8,860 1,881
Public Fundamental Data provided by Morningstar, Inc. disclaimer

UNV Medicine Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore UNV Medicine‘s full profile, request access.

Request a free trial

UNV Medicine Patents

UNV Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3114916-A1 Compositions comprising cbd for treating anorectal disorders Inactive 02-Oct-2018
EP-3860588-A1 Compositions comprising cbd for treating anorectal disorders Inactive 02-Oct-2018
EP-3860588-A4 Compositions comprising cbd for treating anorectal disorders Inactive 02-Oct-2018
US-20220000796-A1 Compositions comprising cbd for treating anorectal disorders Inactive 02-Oct-2018
WO-2020070741-A1 Compositions comprising cbd for treating anorectal disorders Inactive 02-Oct-2018 A61P9/14
To view UNV Medicine’s complete patent history, request access »

UNV Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UNV Medicine Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore UNV Medicine‘s full profile, request access.

Request a free trial

UNV Medicine Acquisitions (3)

UNV Medicine’s most recent deal was a Merger/Acquisition with NeuroNOS Israel. The deal was made on 25-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NeuroNOS Israel 25-Aug-2026 Merger/Acquisition Drug Discovery
Medipharm Pharmacy 14-Jun-2022 Merger/Acquisition Specialty Retail
D-Pharm 28-Mar-2018 Merger/Acquisition Therapeutic Devices
To view UNV Medicine’s complete acquisitions history, request access »

UNV Medicine ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view UNV Medicine’s complete esg history, request access »

UNV Medicine Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Medipharm Pharmacy Holon, Israel 2007

UNV Medicine FAQs

  • When was UNV Medicine founded?

    UNV Medicine was founded in 2016.

  • Where is UNV Medicine headquartered?

    UNV Medicine is headquartered in Tel Aviv, Israel.

  • What is the size of UNV Medicine?

    UNV Medicine has 25 total employees.

  • What industry is UNV Medicine in?

    UNV Medicine’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is UNV Medicine a private or public company?

    UNV Medicine is a Public company.

  • What is UNV Medicine’s stock symbol?

    The ticker symbol for UNV Medicine is UNVO-M.

  • What is the current stock price of UNV Medicine?

    As of 18-Nov-2026 the stock price of UNV Medicine is $16.28.

  • What is the current market cap of UNV Medicine?

    The current market capitalization of UNV Medicine is $5.35K.

  • What is UNV Medicine’s current revenue?

    The trailing twelve month revenue for UNV Medicine is $13.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process